3.2(top 10%)
impact factor
1.6K(top 10%)
papers
24.7K(top 10%)
citations
61(top 10%)
h-index
3.3(top 10%)
impact factor
2.2K
all documents
28.1K
doc citations
101(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Non-small cell lung cancer: current treatment and future advancesTranslational Lung Cancer Research20161,256
2Targeted therapy for non-small cell lung cancer: current standards and the promise of the futureTranslational Lung Cancer Research2015499
3The epidemiology of lung cancerTranslational Lung Cancer Research2018488
4Global trends of lung cancer mortality and smoking prevalenceTranslational Lung Cancer Research2015306
5Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicitiesTranslational Lung Cancer Research2015303
6Recurrence after surgery in patients with NSCLCTranslational Lung Cancer Research2014293
7Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a reviewTranslational Lung Cancer Research2015241
8Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)Translational Lung Cancer Research2019178
9Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypesTranslational Lung Cancer Research2018173
10Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancerTranslational Lung Cancer Research2015173
11Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistanceTranslational Lung Cancer Research2016166
12Methods of measurement for tumor mutational burden in tumor tissueTranslational Lung Cancer Research2018166
13Pros: Can tissue biopsy be replaced by liquid biopsy?Translational Lung Cancer Research2016162
14Current standards for clinical management of small cell lung cancerTranslational Lung Cancer Research2018161
15Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and cliniciansTranslational Lung Cancer Research2018152
16Current state of immunotherapy for non-small cell lung cancerTranslational Lung Cancer Research2007150
17Radiomics of pulmonary nodules and lung cancerTranslational Lung Cancer Research2017150
18Epigenetics in non-small cell lung cancer: from basics to therapeuticsTranslational Lung Cancer Research2016121
19Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testingTranslational Lung Cancer Research2016114
20Treatment for small cell lung cancer, where are we now?-a reviewTranslational Lung Cancer Research2016110
21Classification of pulmonary neuroendocrine tumors: new insightsTranslational Lung Cancer Research2017104
22Lung cancer in never smokers—the East Asian experienceTranslational Lung Cancer Research2018104
23Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancerTranslational Lung Cancer Research2015103
24Tobacco and the lung cancer epidemic in ChinaTranslational Lung Cancer Research2019102
25The clinical utility of tumor mutational burden in non-small cell lung cancerTranslational Lung Cancer Research201898
26Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysisTranslational Lung Cancer Research201797
27Targeting DNA damage repair in small cell lung cancer and the biomarker landscapeTranslational Lung Cancer Research201896
28The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trialsTranslational Lung Cancer Research201995
29Lung cancer prediction using machine learning and advanced imaging techniquesTranslational Lung Cancer Research201893
30Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatmentTranslational Lung Cancer Research201991
31Cancer stem cells and immunoresistance: clinical implications and solutionsTranslational Lung Cancer Research201591
32Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-artTranslational Lung Cancer Research201590
33Small cell lung cancer (SCLC): no treatment advances in recent yearsTranslational Lung Cancer Research201689
34Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patientsTranslational Lung Cancer Research201688
35Lung cancer molecular epidemiology in China: recent trendsTranslational Lung Cancer Research201487
36Tobacco smoking after diagnosis of cancer: clinical aspectsTranslational Lung Cancer Research201985
37Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)Translational Lung Cancer Research201585
38Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?Translational Lung Cancer Research201384
39The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerTranslational Lung Cancer Research201680
40Radiomics and artificial intelligence in lung cancer screeningTranslational Lung Cancer Research202180
41Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoringTranslational Lung Cancer Research201679
42Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos useTranslational Lung Cancer Research202079
43Application of immunohistochemistry in diagnosis and management of malignant mesotheliomaTranslational Lung Cancer Research202077
44Environmental and occupational determinants of lung cancerTranslational Lung Cancer Research201976
45Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progressionTranslational Lung Cancer Research201975
46Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanismsTranslational Lung Cancer Research201974
47Treatment of advanced squamous cell carcinoma of the lung: a reviewTranslational Lung Cancer Research201574
48The role of the immune system in non-small cell lung carcinoma and potential for therapeutic interventionTranslational Lung Cancer Research201573
49Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?Translational Lung Cancer Research201672
50Angiogenesis in cancer: Anti-VEGF escape mechanismsTranslational Lung Cancer Research201272